AMD Acquisition Of Xilinx CompletesGemma Cann2024-11-28T15:14:13+00:00February 21st, 2022|Edinburgh Technopole, News|
Cellomatics Biosciences Goes For Growth With Senior Business Development HireGemma Cann2024-11-28T15:14:39+00:00February 21st, 2022|News|
Phenotypeca Wins A Third Grant From Innovate UKGemma Cann2024-11-28T15:14:49+00:00February 17th, 2022|News|
Winners Announced For Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:16:09+00:00February 15th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Nottingham CRO Bolsters Team With Appointment Of Senior Molecular BiologistGemma Cann2024-11-28T15:29:53+00:00February 14th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Phenotypeca Announces Commencement Of Lab 4.0 ProjectGemma Cann2024-11-28T15:16:33+00:00February 4th, 2022|BioCity Nottingham, News|
Myconoes Wins £21k Innovate UK GrantGemma Cann2022-06-30T11:43:27+01:00February 2nd, 2022|BioCity Nottingham, News|
New Partnerships With Leading FirmsGemma Cann2024-11-28T15:16:48+00:00January 25th, 2022|Accelerator, News|
Pioneer Group Accelerator Winner AnnouncedGemma Cann2023-09-04T12:44:36+01:00January 21st, 2022|Accelerator, News|
